Chemotherapy regimen checks performed by pharmacists contribute to safe administration of chemotherapy
- 9 July 2016
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 23 (1) , 18-25
Abstract
Computerized provider order entry (CPOE) has been developed and implemented within cancer center hospitals nationwide in Japan. To ensure that high-quality services are routinely provided by oncology pharmacists, this study was designed to evaluate the interventions through reviewing the orders that are generated by CPOE. The objective of this retrospective chart review was to evaluate how pharmacists contributed to safe cancer treatment using paper-based pharmacy records. Data were collected from a total of 35,062 chemotherapy regimens for 18,515 outpatients between January and December 2013. Of these 35,062 chemotherapy regimens, the rate of pharmacists’ interventions was 1.1% (n = 408). Among them, 53.1% (217/408) of the chemotherapy prescriptions were modified due to pharmacist interventions. The reasons for interventions included “changes in the chemotherapy regimen were unclear” in 49.5%, “physicians’ prescription errors” (22.0%), “pharmacist suggestions to improve chemotherapy” (15.1%), and “finding differences between physicians’ chemotherapy records and their chemotherapy prescriptions” (13.2%). The top three reasons for the 217 prescription modifications due to pharmacist interventions were “finding prescription errors” (34.5%), “reasons for change in the chemotherapy regimen were unclear” (32.7%), and “finding differences between physicians’ chemotherapy records and their chemotherapy prescriptions” (28.5%). The computer could not evaluate chemotherapy protocols or adjust doses of anticancer medicines according to patients’ conditions. Therefore, oncology pharmacists should continue to ensure safe and appropriate administration of cancer chemotherapy.Keywords
This publication has 16 references indexed in Scilit:
- Studies Regarding Quality Enhancement of Affairs by Pharmacist and Clinical Evaluation of Cancer ChemotherapyIryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2015
- Evaluation of the impact of a flowchart-type leaflet for cancer inpatientsSage Open Medicine, 2014
- Does applying technology throughout the medication use process improve patient safety with antineoplastics?Journal of Oncology Pharmacy Practice, 2013
- Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards: Expanding the Scope to Include Inpatient SettingsJournal of Oncology Practice, 2012
- Evaluation of Improvement of Adherence Following Pharmacist Intervention for Hand/Foot Skin Reactions Induced by SorafenibIryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2011
- Adherence in Use of Oral Antibiotics for Fever in Outpatient Docetaxel ChemotherapyIryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2011
- Pharmacists versus nonpharmacists in adverse drug event detection: A meta-analysis and systematic reviewAmerican Journal of Health-System Pharmacy, 2007
- The impact of a supplementary medication review and counselling service within the oncology outpatient settingBritish Journal of Cancer, 2007
- Role of Pharmacist Counseling in Preventing Adverse Drug Events After HospitalizationArchives of internal medicine (1960), 2006
- Relationship between medication errors and adverse drug eventsJournal of General Internal Medicine, 1995